Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines

Figure 1

AZ and/or SFN Treatment Inhibit Growth of Lung Carcinoid and Fetal Lung Fibroblast Cells (H-727 and H-720); 48 hours, 7 days) and (FLF): AlamarBlue assay; dose response for AZ, SFN and AZ + SFN; (0-80 μM) treatment in H-727 (a,b and c), H-720 (d, e and f) cells 48 hours (gray) and 7 days (white) and AlamarBlue assay; dose response for AZ (white), SFN (gray) and AZ + SFN (black); (0-80 μM) treatment in FLF (g, h and i) cells, 7 days. The significance level compared to control (p value) was specified as follows: *(p < 0.05), **(p < 0.01), ***(p < 0.001) and ****(p < 0.0001).

Back to article page